ScienceDaily (Apr. 1, 2008) — Determining the structure of unknown natural compounds is a slow and expensive part of drug screening and development -- but this may now change thanks to a new combination of experimental and computational protocols developed at the University of California, San Diego and presented at RECOMB 2008 (Research in Computational Molecular Biology) in Singapore.
